Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy von Dickstein, D L, Pullman, M Y, Fernandez, C, Short, J A, Kostakoglu, L, Knesaurek, K, Soleimani, L, Jordan, B D, Gordon, W A, Dams-O'Connor, K, Delman, B N, Wong, E, Tang, C Y, DeKosky, S T, Stone, J R, Cantu, R C, Sano, M, Hof, P R, Gandy, S

Volltext

Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments von Jemaa, S, Paulson, J. N, Hutchings, M, Kostakoglu, L, Trotman, J, Tracy, S, de Crespigny, A, Carano, R. A. D, El-Galaly, T. C, Nielsen, T. G, Bengtsson, T

Volltext

Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma? von Gallamini, A., Kostakoglu, L.

Volltext

Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury von Mitsis, E M, Riggio, S, Kostakoglu, L, Dickstein, D L, Machac, J, Delman, B, Goldstein, M, Jennings, D, D’Antonio, E, Martin, J, Naidich, T P, Aloysi, A, Fernandez, C, Seibyl, J, DeKosky, S T, Elder, G A, Marek, K, Gordon, W, Hof, P R, Sano, M, Gandy, S

Volltext

An automated quantification algorithm for evaluating total metabolic tumor volume in patients with FDG‐avid lymphomas using a deep learning model von Xu, T., Jemaa, S., Kumar, M., Balasubramanian, S., Shamas‐Din, A., Lyalina, S., Ounadjela, S., Malik, B., Lee, J., Morales, S. Figueroa, Nielsen, T., Carano, R. A. D., Kostakoglu, L., Capra, W.

Volltext

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients von Eertink, J.J., Burggraaff, C.N., Heymans, M.W., Dührsen, U., Hüttmann, A., Schmitz, C., Müller, S., Lugtenburg, P.J., Barrington, S.F., Mikhaeel, N.G., Carr, R., Czibor, S., Györke, T., Ceriani, L., Zucca, E., Hutchings, M., Kostakoglu, L., Loft, A., Fanti, S., Wiegers, S.E., Pieplenbosch, S., Boellaard, R., Hoekstra, O.S., Zijlstra, J.M., de Vet, H.C.W.

Volltext

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826 von Herrera, A. F., LeBlanc, M., Castellino, S. M., Li, H., Rutherford, S. C., Evens, A. M., Davison, K., Punnett, A., Hodgson, D., Parsons, S. K., Ahmed, S., Casulo, C., Bartlett, N. L., Tuscano, J. M., Mei, M. G., Hess, B. T., Jacobs, R., Saeed, H., Torka, P., Hu, B., Moskowitz, C., Kaur, S., Goyal, G., Forlenza, C., Doan, A., Lamble, A., Kumar, P., Chowdhury, S., Brinker, B., Sharma, N., Singh, A., Blum, K., Perry, A. M., Kovach, A., Constine, L. S., Shields, L. Kostakoglu, Prica, A., Little, R. F., Shipp, M. A., Crump, M., Kahl, B., Leonard, J. P., Smith, S. M., Song, J. Y., Kelly, K. M., Friedberg, J. W.

Volltext

CALGB 50801 (ALLIANCE): PET ADAPTED THERAPY IN BULKY STAGE I/II CLASSIC HODGKIN LYMPHOMA (CHL) von LaCasce, A. S., Dockter, T., Ruppert, A., Kostakoglu, L., Schöder, H., Hsi, E. D., Bogart, J. A., Cheson, B. D., Wagner‐Johnston, N. D., Abramson, J. S., Maddocks, K. J., Leonard, J. P., Bartlett, N. L.

Volltext

BASELINE TOTAL METABOLIC TUMOUR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL von Trněný, M., Canales Ruiz, I., Martelli, M., Sehn, L.H., Vitolo, U., Brown, H., Nielsen, T., Sellam, G., Kostakoglu, L.

Volltext

RADIOMICS INCREASE THE PROGNOSTIC VALUE OF CLINICAL AND PET RISK FACTORS IN DLBCL: RESULTS FROM THE PHASE 3 GOYA STUDY von Chauvie, S., Dalmasso, F., Pierce, L., Vitolo, U., Martelli, M., Sehn, L.H., Trněný, M., Nielsen, T., Sahin, D., Lee, C., Mattiello, F., Berchialla, P., Kinahan, P.E., Kostakoglu, L.

Volltext

PET‐CR AS A SURROGATE FOR SURVIVAL OUTCOMES IN DLBCL: A LITERATURE BASED META‐ANALYSIS von Berry, D.A., Broglio, K.R., Ward, C., Sahin, D., Nielsen, T., Mattiello, F., McGlothlin, A.E., Wendelberger, B.A., Foster, M., Nowakowski, G.S., Kostakoglu, L.

Volltext

ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTER... von Nowakowski, G.S., Hong, F., Scott, D.W., Macon, R., King, R.L., Habermann, T.M., Wagner‐Johnston, N., Casulo, C., Wade, J.L., Nagargoje, G.G., Reynolds, C.M., Cohen, J.B., Khan, N., Amengual, J., Richards, K.L., Little, R.F., Leonard, J.P., Friedberg, J.W., Kostakoglu, L., Kahl, B.S., Witzig, T.E.

Volltext

The Significance and Management of Incidental [18F]Fluorodeoxyglucose-Positron-Emission Tomography Uptake in the Thyroid Gland in Patients with Cancer von Eloy, J.A, Brett, E.M, Fatterpekar, G.M, Kostakoglu, L, Som, P.M, Desai, S.C, Genden, E.M

Volltext

Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure von Dickstein, Dara L., De Gasperi, Rita, Gama Sosa, Miguel A., Perez-Garcia, Georgina, Short, Jennifer A., Sosa, Heidi, Perez, Gissel M., Tschiffely, Anna E., Dams-O’Connor, Kristen, Pullman, Mariel Y., Knesaurek, Karin, Knutsen, Andrew, Pham, Dzung L., Soleimani, Lale, Jordan, Barry D., Gordon, Wayne A., Delman, Bradley N., Shumyatsky, Gleb, Shahim, Pashtun-Poh, DeKosky, Steven T., Stone, James R., Peskind, Elaine, Blennow, Kaj, Zetterberg, Henrik, Chance, Steven A., Torso, Mario, Kostakoglu, Lale, Sano, Mary, Hof, Patrick R., Ahlers, Stephen T., Gandy, Sam, Elder, Gregory A.

Volltext

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale von Gallamini, Andrea, Barrington, Sally F, Biggi, Alberto, Chauvie, Stephane, Kostakoglu, Lale, Gregianin, Michele, Meignan, Michel, Mikhaeel, George N, Loft, Annika, Zaucha, Jan M, Seymour, John F, Hofman, Michael S, Rigacci, Luigi, Pulsoni, Alessandro, Coleman, Morton, Dann, Eldad J, Trentin, Livio, Casasnovas, Olivier, Rusconi, Chiara, Brice, Pauline, Bolis, Silvia, Viviani, Simonetta, Salvi, Flavia, Luminari, Stefano, Hutchings, Martin

Volltext

END OF TREATMENT PET‐CT PREDICTS PROGRESSION‐FREE SURVIVAL IN DLBCL AFTER FIRST‐LINE TREATMENT: RESULTS FROM THE PHASE III GOYA STUDY von Kostakoglu, L., Martelli, M., Belada, D., Carella, A.M., Chua, N., Gonzalez‐Barca, E., Hong, X., Pinto, A., Sehn, L.H., Shi, Y., Tatsumi, Y., Fingerle‐Rowson, G., Mattiello, F., Nielsen, T., Sahin, D., Vitolo, U., Trněný, M.

Volltext

Clinical role of FDG PET in evaluation of cancer patients von Kostakoglu, Lale, Agress, Jr, Harry, Goldsmith, Stanley J

Volltext

High Uptake in Schneiderian Papillomas of the Maxillary Sinus on Positron-Emission Tomography Using Fluorodeoxyglucose von Lin, F.Y, Genden, E.M, Lawson, W.L, Som, P, Kostakoglu, L

Volltext

Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer von MILOWSKY, Matthew I, NANUS, David M, KOSTAKOGLU, Lale, VALLABHAJOSULA, Shankar, GOLDSMITH, Stanley J, BANDER, Neil H

Volltext

Application of 18-F Fluciclovine PET/CT in Guiding Salvage Radiation Therapy for Recurrent Prostate Cancer von Ahmed, J., Muhleman, M., Chong, J., Tewari, A., Oh, W., Kostakoglu, L., Stock, R.G.

Volltext